New Treatment in Australia: A Potential Breakthrough for Weight Loss ?
Australia is eagerly anticipating the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a exciting advance in weight loss . Early study data have demonstrated impressive results, showing greater effectiveness than existing treatments like semaglutide. While awaiti